Las pistolas de bolas de pintura se están usando para hacer daño… y dejan ciegas a las víctimas
MARTES, 19 de julio de 2022 (HealthDay News) — Cuando una bola de pintura (paintball) sale disparada de una pistola de CO2, puede desplazarse hasta 300 pies (91 metros) por segundo.Si se apunta en dirección de la cara, esta bola de pintura (que se di…
Learn MoreUnos exámenes de ginecoobstetricia serán virtuales por el miedo a la COVID y el fallo sobre el aborto
MARTES, 19 de julio de 2022 (HealthDay News) — A la luz del reciente fallo de la Corte Suprema que anuló Roe contra Wade, muchos obstetras y ginecólogos en todo el país aprecian un cambio que les permite seguir realizando los exámenes de acreditación…
Learn MoreUsar marihuana podría reducir el rendimiento de las deportistas
MARTES, 19 de julio de 2022 (HealthDay News) — El uso médico y recreativo de la marihuana se ha disparado en Estados Unidos, a medida que más estados legalizan la droga, pero las jóvenes deportistas quizá deban pensárselo dos veces antes de usarla.Un…
Learn MoreLa viscosidad de la sangre podría tener un rol en el riesgo de muerte por COVID
MARTES, 19 de julio de 2022 (HealthDay News) — La viscosidad de la sangre de una persona podría ser cuestión de vida o muerte si contrae la COVID-19, sugiere un estudio reciente.Los pacientes hospitalizados con COVID-19 que tienen una mayor viscosida…
Learn MoreFreeze-Dried Organic Blueberries Recalled Due to Lead Levels
WEDNESDAY, July 20, 2022 (HealthDay News) — Certain 1.2-ounce Natierra Organic Freeze-Dried Blueberry pouches have been recalled in the United States because of possible lead contamination.The recall of two lots by manufacturer BrandStorm Inc. is due…
Learn MoreHormone Replacement Therapy Won’t Raise Recurrence Rate for Breast Cancer Survivors
WEDNESDAY, July 20, 2022 (HealthDay News) — Hormone replacement therapy (HRT) for breast cancer survivors doesn’t appear to increase the risk of cancer recurrence or death, Danish researchers report.Although HRT has previously been linked to a raised…
Learn MoreFDA Approves First Topical Treatment for Vitiligo
WEDNESDAY, July 20, 2022 (HealthDay News) — The U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) as the first topical treatment for vitiligo. The 1.5 percent cream is approved for continuous topical use twice daily to affected ar…
Learn MoreRegular Screening Pays Off for People at High Risk for Pancreatic Cancer
WEDNESDAY, July 20, 2022 (HealthDay News) — Pancreatic cancer often has a dismal prognosis, but a new study finds that screening high-risk people can catch the disease early and extend lives.Researchers at eight U.S. medical centers found that annual…
Learn MoreAHA News: Rethink What You Thought You Knew About COVID-19 Reinfection
WEDNESDAY, July 20, 2022 (American Heart Association News) — Forget what you thought you knew about catching COVID-19 more than once. SARS-CoV-2, the virus that causes COVID-19, keeps evolving – and so has information about your risk of being reinfec…
Learn More2016 to 2020 Saw Increase in Rates of GDM Across United States
WEDNESDAY, July 20, 2022 (HealthDay News) — The rates of gestational diabetes mellitus (GDM) increased from 2016 to 2020, according to the July 19 issue of the National Vital Statistics Reports, a publication from the U.S. Centers for Disease Contro…
Learn More